Allergy Therapeutics PLC (GB:AGY)
LSE:AGY
| Jun 25 | Jun 24 | Jun 23 | Jun 22 | Jun 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | £ 55.04M | £ 55.20M | £ 59.59M | £ 72.77M | £ 84.33M |
| Gross Profit | £ 25.13M | £ 29.74M | £ 32.69M | £ 48.95M | £ 61.80M |
| Operating Income | £ -29.50M | £ -35.26M | £ -34.85M | £ -13.00M | £ 4.03M |
| EBITDA | £ -29.43M | £ -30.74M | £ -36.24M | £ -8.69M | £ 7.61M |
| Net Income | £ -40.13M | £ -40.22M | £ -43.07M | £ -13.78M | £ 2.89M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | £ 12.79M | £ 12.91M | £ 14.85M | £ 20.52M | £ 40.27M |
| Total Assets | £ 67.54M | £ 64.83M | £ 66.77M | £ 72.95M | £ 88.09M |
| Total Debt | £ 60.09M | £ 30.99M | £ 35.99M | £ 10.53M | £ 11.17M |
| Net Debt | £ 47.50M | £ 18.07M | £ 21.14M | £ -9.99M | £ -29.10M |
| Total Liabilities | £ 95.74M | £ 61.12M | £ 64.70M | £ 35.18M | £ 39.55M |
| Stockholders' Equity | £ -28.19M | £ 3.71M | £ 2.07M | £ 37.77M | £ 48.53M |
| Cash Flow | |||||
| Free Cash Flow | £ -31.98M | £ -35.54M | £ -35.59M | £ -17.17M | £ 5.95M |
| Operating Cash Flow | £ -28.72M | £ -32.14M | £ -30.92M | £ -14.11M | £ 8.52M |
| Investing Cash Flow | £ -3.15M | £ -1.20M | £ -4.67M | £ -3.06M | £ -2.76M |
| Financing Cash Flow | £ 32.04M | £ 31.43M | £ 29.91M | £ -2.64M | £ -2.03M |